SC 13G
 
 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. __)*

TorreyPines Therapeutics, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
89235K105
(CUSIP Number)
June 1, 2009
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

þ Rule 13d-1(c)

o Rule 13d-1(d)

Page 1 of 5

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 

SCHEDULE 13G
                         
CUSIP No.
  
89235K105 
   Page  
2 
   of   
5 
   Pages

 

           
1   NAME OF REPORTING PERSON

Lloyd I. Miller, III
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   252,869
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   683,316
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   252,869
       
WITH 8   SHARED DISPOSITIVE POWER
     
    682,316
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  935,185
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  5.8%
     
12   TYPE OF REPORTING PERSON
   
  IN-IA-OO **
*SEE INSTRUCTIONS BEFORE FILLING OUT!
** See Item 4.

 

                     
 
 
   Page  
3 
   of   
5 
         
Item 1(a).
  Name of Issuer:   TorreyPines Therapeutics, Inc.
 
        
Item 1(b).
  Address of Issuers’s Principal Executive Offices:   11085 North Torrey Pines Road
Suite 300
 
      La Jolla, California 92037
 
        
Item 2(a).
  Name of Person Filing:   Lloyd I. Miller, III
 
        
Item 2(b).
  Address of Principal Business Office or, if None, Residence:   4550 Gordon Drive, Naples, Florida 34102
 
        
Item 2(c).
  Citizenship:   U.S.A.
 
        
Item 2(d).
  Title of Class of Securities:   Common Stock
 
        
Item 2(e).
  CUSIP Number:   89235K105
Item 3.    IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b) OR 13d-2(b) or (c), CHECK WHETHER THE PERSON FILING IS A:
 
    Not Applicable, this statement is filed pursuant to 13d-1(c)
 
Item 4.    OWNERSHIP: The reporting person has shared dispositive and voting power with respect to 682,316 shares of the reported securities as an investment advisor to the trustee of certain family trusts. The reporting person has sole dispositive and voting power with respect to 252,869 of the reported securities as (i) a manager of a limited liability company that is the general partner of a certain limited partnership, (ii) the custodian to an account set up under the Florida Uniform Gift to Minors Act, (iii) the trustee of certain generation skipping trusts, and (iv) an individual.
  (a)   935,185
 
  (b)   5.8%
 
  (c)   (i) sole voting power: 252,869
  (ii)   shared voting power: 682,316
 
  (iii)   sole dispositive power: 252,869
 
  (iv)   shared dispositive power: 682,316
Item 5.    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
 
    Not Applicable
 
Item 6.    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
 
    Other than shares held directly by Lloyd I. Miller, III, persons other than Lloyd I. Miller, III have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the reported securities.
 
Item 7.    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
 
    Not Applicable

 

 

                     
 
 
   Page  
4 
   of   
5 
Item 8.    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
 
    Not Applicable
 
Item 9.    NOTICE OF DISSOLUTION OF GROUP:
 
    Not Applicable
 
Item 10.    CERTIFICATION:
 
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

                     
 
 
   Page  
5 
   of   
5 
SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
         
     
Dated: June 5, 2009  /s/ Lloyd I. Miller, III    
  Lloyd I. Miller, III